Decrelip en es it fr

Decrelip Brand names, Decrelip Analogs

Decrelip Brand Names Mixture

  • No information avaliable

Decrelip Chemical_Formula


Decrelip RX_link

Decrelip fda sheet

Decrelip FDA

Decrelip msds (material safety sheet)

Decrelip Synthesis Reference

P. L. CREGER, U.S. Pat. 3,674,836 (1972)

Decrelip Molecular Weight

250.333 g/mol

Decrelip Melting Point

61-63 oC

Decrelip H2O Solubility

10 mg/mL (in base)

Decrelip State


Decrelip LogP


Decrelip Dosage Forms

Tablets; Capsules

Decrelip Indication

For treatment of adult patients with very high elevations of serum triglyceride levels (types IV and V hyperlipidemia) who are at risk of developing pancreatitis (inflammation of the pancreas) and who do not respond adequately to a strict diet.

Decrelip Pharmacology

Gemfibrozil, a fibric acid antilipemic agent similar to clofibrate, is used to treat hyperlipoproteinemia and as a second-line therapy for type IIb hypercholesterolemia. It acts to reduce triglyceride levels, reduce VLDL levels, reduce LDL levels (moderately), and increase HDL levels (moderately).

Decrelip Absorption

Well absorbed from gastrointestinal tract (within 1-2 hours).

Decrelip side effects and Toxicity

Oral, mouse: LD50 = 3162 mg/kg. Symptoms of overdose include abdominal cramps, diarrhea, joint and muscle pain, nausea, and vomiting.

Decrelip Patient Information

Gemfibrozil is used to lower high triglyceride and cholesterol levels. Notify your physician if you are pregnant or nursing. Gemfibrozil should be taken 30 minutes before the morning and evening meals. This medication may cause dizziness or blurred vision; use caution while driving or operating hazardous machinery. Gemfibrozil may cause an increase in blood sugar. If you have diabetes mellitus, carefully monitor blood sugar levels. Notify your physician if you develop severe stomach pain, muscle pain or weakness, or unexplained fever.

Decrelip Organisms Affected

Humans and other mammals